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Abstract  
 
Subjects participating in magnetic resonance imaging (MRI) examinations regularly report 
anxiety and stress related reactions. This may result in impaired data quality and premature 
termination of scans. Moreover, cognitive functions and neural substrates can be altered by 
stress. While prior studies investigated pre–post scan differences in stress reactions only, the 
present study provides an in-depth analysis of mood changes and hormonal fluctuations 
during the time course of a typical fMRI session. Thirty-nine subjects participated in the 
study. Subjective mood, salivary alpha-amylase (sAA) and cortisol were assessed at six time 
points during the lab visit. Associations between hormonal data and neural correlates of a 
visual detection task were observed using a region of interest approach applied to the thalamic 
region. Mood and hormonal levels changed significantly during the experiment. Subjects were 
most nervous immediately after entering the scanner. SAA was significantly elevated after 
MRI preparation. A subgroup of n=5 (12.8%) subjects showed pronounced cortisol responses 
exceeding 2.5 nmol/l. Preliminary fMRI data revealed an association between sAA levels and 
left thalamic activity during the first half of the experiment that disappeared during the second 
half. No significant correlation between cortisol and thalamic activity was observed. Results 
indicate that an fMRI experiment may elicit subjective and neuroendocrine stress reactions 
that can influence functional activation patterns.   
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1. Introduction  
 
Although affective response systems have been extensively studied within the last decade 
using functional magnetic resonance imaging (fMRI), surprisingly less is known about the 
stress-eliciting properties of the scanner itself. Anxiety-related reactions were often reported 
by routine care patients undergoing an MRI examination (Melendez and McCrank, 1993). 
The claustrophobic properties of the scanner, discomfort, loudness, a low sense of control and 
the novelty of the situation can act as stressful factors. Moreover, worries about 
innocuousness of the procedure or pathological incidental findings can result in anxiety and 
stress (Katz et al., 1994). These adverse reactions can be followed by impaired data quality 
and premature terminations of scans.  
 
Evidence is accumulating that anticipation of an MRI examination can affect subjective as 
well as neuroendocrine stress markers. Dantendorfer et al. (1997) found that state anxiety is 
significantly higher in pre- than post-scan measurements. Increased activation of the SAM as 
indicated by salivary alpha-amylase (sAA) was reported by van Stegeren et al. (2006) 
immediately before the scanning onset. In a repeated measurements design of six participants, 
Tessner et al. (2006) found that adult subjects with no previous scanning experience (e.g. 
scanner-naive subjects) showed an activation of the HPA axis as indicated by increased levels 
of salivary cortisol after scanning at the first day of examination, but not during repetition 
after one week. Similarly, in an examination of 160 adolescents Eatough et al. (2009) 
evaluated HPA and hypothalamic-pituitarygonadal (HPG) axis reactions via salivary cortisol, 
dehydroepiandrostosterone and testosterone. All three hormonal levels showed increases after 
an fMRI, but not after a simulation scan at a mock scanner. Moreover, the cognitive task 
being conducted in the scanner can also exhibit stress-eliciting properties. Kukolja et al. 
(2008b) reported that some of the subjects undergoing a cognitive challenging memory task in 
the scanner showed cortisol responses similar to those observed after psychosocial stress 
exposure such as the Trier Social Stress Test (TSST, Kirschbaum et al., 1993).  
 
It is well known that stress acts upon various hormonal response systems, including the 
sympatho-adrenal-medullary (SAM) and hypothalamic-pituitary-adrenal (HPA) axis with 
glucocorticoids (CG) and catecholamines as their primary effectors. On a central nervous 
level, activation of the locus coeruleus noradrenaline (LC-NA) system and the solitary tract 
may influence tonic as well as phasic neuronal activity throughout the brain (Aston-Jones and 
Cohen, 2005; Valentino and van Bockstaele, 2008). Central NA binds to multiple sites such as 
amygdala, bed nucleus of the stria terminalis, prefrontal cortex, and lateral septum (Morilak et 
al., 2005). A high density of GC binding receptors is located in hippocampal and prefrontal 
structures (Reul and de Kloet, 1986). In accordance with these neuroanatomical findings, 
modulating effects of GC as well as NA were repeatedly demonstrated for a wide range of 
cognitive functions like working memory (Elzinga and Roelofs, 2005; Oei et al., 2006, 2009; 
Lupien et al., 2007; Schoofs et al., 2008; Weerda et al., 2010), declarative memory (de 
Quervain et al., 2000, 2003; Buchanan et al., 2006), emotional information processing and 
memory (van Stegeren et al., 2006; Wolf, 2008; Kukolja et al., 2008a), and temporal orienting 
(Coull et al., 2001). Several neuroimaging studies provide evidence for a relationship between 
NA effects and regions of the attention and arousal network, for example the thalamus 
(Kinomura et al., 1996; Coull et al., 2004; Bruhl et al., 2010). It is thus plausible to assume 
that stress induced by the MRI environment may influence functional activation patterns that 
are subject to neuroimaging research. Regarding clinical research it should moreover be 
anticipated that compared to healthy controls, specific patient groups vulnerable to the stress 
eliciting properties of the scanner (e.g. anxiety patients) may respond with enhanced stress 
reactions. Comparison of patient and control groups could hence be confounded by different 
stress levels.  
 
In summary, first studies point towards the potentially stress-eliciting properties of the MRI 
environment. These unintended effects are especially important with regard to neuroimaging 
research where they could act as potential confounders of functional data. This demonstrates 
the need for a comprehensive examination of how different stress response systems may 
change during the time course of an fMRI session. Simple pre–post scanning differences as 
used in previous studies may be insufficient to detect different response latencies and 
hormonal changes throughout the entire fMRI session. The aim of the present study was to 
observe the extent to which subjective and bodily stress systems will get activated during an 
fMRI session and may in turn influence functional activation patterns of interest. In order to 
get more information about the scanning epoch itself, we implemented several assessment 
points during the experiment, including a mood questionnaire and hormonal measurements of 
sAA for SAM (Nater and Rohleder, 2009) and salivary cortisol for HPA reactivity 
(Kirschbaum and Hellhammer, 1994). Based on previous findings about the potential stress-
eliciting effects of the MRI environment we predicted that subjective and hormonal stress 
components would be elevated in response to the scanner session, but not in response to a lab 
training session prior to the scanner session. Moreover, we predicted a relationship between 
hormonal levels and functional brain activation in structures subserving attention and arousal.  
 
 
2. Methods  
 
2.1. Subjects and procedure  
 
Thirty-nine student volunteers from the Technische Universität Dresden (Germany) were 
recruited using flyers and public announcements (male: n=34 (87.2%); mean age=23.8 (±2.1); 
female: n=5 (12.8%); mean age=23.8 (±4.8)). Thirty-six subjects had never undergone an 
MRI or CT examination before yet (e.g. 92.3% scanner-naive subjects). Exclusion criteria 
included smoking, oral contraceptives, body mass index above 26, any history of acute or 
chronic medical disease or failure to meet basic MRI compatibility. Subjects received course 
credit or 10€ for participation. All participating subjects gave their informed consent, thus 
complying with the standards laid down in the Declaration of Helsinki. The study protocol 
was approved by the local ethics committee.  
 
All assessments took place between 11:00 and 18:30, thus omitting morning times where 
cortisol levels show the most pronounced changes in diurnal rhythm. Subjects were asked to 
come well rested to testing and were also requested not to eat or drink one hour before the 
experiment. After entering the lab, subjects were informed about the study protocol and MRI 
procedure (see Fig. 1 for protocol details). To ensure that all participants had adequate levels 
of blood glucose they received 2 dl grape juice immediately after the first saliva sample in 
order to avoid a hyporeaction of the HPA axis due to low glucose levels (Kirschbaum et al., 
1997). We then conducted an extensive training session for the cognitive task consisting of 
600 events in order to avoid further learning effects in the scanner. Afterwards subjects were 
introduced to the scanner room and prepared for the scanning session. The MRI protocol 
encompassed two experimental runs using the same paradigm that were separated by a 
structural scan. Following the scanning session subjects completed several questionnaires. 
During the entire lab visit we established six sampling points (T1–T6) for saliva and state 
affectivity, three of them being conducted while the subjects remained in the scanner 
(synthetic swabs being passed by an assistant). MRI staff was held constant for all subjects in 
order to avoid stress reactions due to differential personal styles and interactions.  
 
2.2. Measures  
 
2.2.1. State and trait affectivity  
 
A mood profile from the entire lab visit was collected using the Multidimensional Mood 
Questionnaire (Mehrdimensionaler Befindlichkeitsfragebogen: MDBF, Steyer et al., 1994, 
1997), which is suitable to measure short term fluctuations within several minutes. The 
MDBF in its long form consists of 24 items assessing three mood dimensions (valence: high 
valence: good mood, low valence: bad mood; alertness: high alertness: awake, low alertness: 
tired; calmness: high calmness: calm, low calmness: nervous). It can be divided into two 
parallel short forms that were alternated during the assessments. We programmed a 
computerized version of the MDBF using Presentation® 11.3 (Neurobehavioral Systems, 
Inc., CA) that was used during the training session and at the scanner. Due to technical 
problems complete mood profiles could be saved for n=36 subjects.  
 
After completion of the scanner session several questionnaires were used to characterize trait 
affectivity including depressive symptoms (Beck Depression Inventory: BDI II, Hautzinger et 
al., 2006) general anxiety (Anxiety Sensitivity Index: ASI, Hoyer and Markgraf, 2003; Stait 
Trait Anxiety Inventory-Trait Version: STAI, Laux et al., 1981), and claustrophobic anxiety 
(Claustrophobia Questionnaire: CLQ, Radomsky et al., 2001). In order to analyze differences 
in trait affectivity between hormonal subgroups, we subdivided the entire sample according to 
cortisol levels (cortisol responders and non-responders) and to SAA levels (median split 
procedure; see Section 2.2.4) and then compared markers of trait affectivity. BDI II and CLQ 
scores were available for n=38 subjects.  
 
2.2.2. FMRI task, data acquisition and analysis  
 
A visual detection task similar to that used by Coull et al. (2000) was employed in order to 
study effects of the noradrenergic system (as indicated by sAA) on the attention network 
encompassing the thalamus. The task required to direct attentional resources to a particular 
time point. This simple detection task did not contain any stress eliciting properties; 
moreover, subjects received training prior to the fMRI session in order to assure constant 
performance levels. Baseline stimuli were two concentric circles with a small centered 
fixation cross presented foveally on a black background. Each trial started with a brightening 
(100 ms) of one of the circles indicating either a 600 ms (inner circle) or a 1400 ms (outer 
circle) cue-target interval (CTI) followed by the appearance (100 ms) of a large cross (target) 
superimposed over the baseline stimuli. Participants had to detect the target by pressing a 
button with the right index finger as fast as possible. Seven different trial types occurred in a 
pseudo-randomized order for blocks of 200 events. The total number of events per run was 
400 with 235 valid trials (118 short cued, 117 long cued), 55 invalid trials (27 short cued, 28 
long cued), 10 catch trials (5 short and long cues respectively) and 100 Null-Events (Josephs 
and Henson, 1999) were a baseline stimulus was shown. The randomized presentation of 
different trials and null-events leads to variable SOAs to prevent for stimulus-response 
predictability. During valid trials participants had to orient their attention to a time point 600 
ms (short CTI) or 1400 ms (long CTI) after the presentation of the cue stimulus. During the 
invalid trials the CTI was reversed. This required a bottom-up driven re-orientation of 
attention when the target appeared to an unexpected early time point (exogen shifting) or a re-
orientation to an unexpected late time point under voluntary control (endogen shifting). 
During catch trials, only the cue but not the target was shown. Participants who reacted on the 
catch trials more than three times were excluded from the fMRI analysis. Each trial lasted 
2000 ms. The paradigm was programmed using Presentation® 11.3 (Neurobehavioral 
Systems, Inc., CA). Stimuli were presented on video goggles (VisuaStim Digital, Northridge, 
California).  
 
MRI images were acquired using a 3-Tesla Trio-Tim MRI wholebody scanner (Siemens, 
Erlangen, Germany). In each of the runs, 411 volumes of 38 slices with voxel size of 3×3×3 
mm (1 mm gap) were acquired sequentially. The first four scans were discarded to account for 
T1 equilibration effects. A standard 12 channel head coil and standard headphones were 
applied. Functional measurements were obtained using a T2* weighted gradient echo planar 
images (EPI) sequence (repetition time TR 2200 ms, echo time TE 25 ms). Structural images 
were obtained by using a Magnetization Prepared Rapid Gradient Echo Imaging (MPRAGE) 
sequence (repetition time TR 1900 ms, echo time TE 2.26 ms).  
 
FMRI Data were analysed using SPM5 (Welcome Trust Centre for Neuroimaging, UCL, 
London, UK). Functional images of both runs were spatially realigned and unwarped to 
correct for movement artefacts followed by a correction for slice acquisition times. Structural 
images were coregistered to the functional scans and all volumes were normalized to the MNI 
(Montreal Neurological Institute, Quebec, Canada) reference brain. A smoothing kernel with 
8 mm full-with half-maximum was used. At the first level regressors were built for the four 
effects of interest (valid short cue, valid long cue, invalid short cue, invalid long cue) and two 
effects of no interest (catch trial short, catch trial long). All regressors were modeled as single 
events and time locked to the onset of the cue. The general linear model was used to calculate 
regression coefficients (beta values) for the regressors and each voxel. The resulting contrast 
estimates were taken into the second level analysis employing a full factorial design. We 
expected sAA levels to rise directly prior to the first run. Since the NA system exhibits rather 
short response latencies with phasic, short lasting effects (Joels and Baram, 2009), we focused 
our analysis on the first run, subdividing it into two parts in order to investigate time-
dependent effects of the NA system. A region of interest (ROI) approach (ROI-size 1291 
voxel) was applied to the thalamic region using the WFU Pickatlas (Maldjian et al., 2003). 
The estimated beta values were extracted from the peak voxel of the first half of run 1 
employing the average effect of condition (significance threshold p<0.01 family wise error 
corrected for multiple comparisons). Associations between hormonal measures from saliva 
sample 3 and beta values from the four effects of interest were calculated using Pearson's 
correlations that were corrected for multiple comparisons (Bonferroni corrections; adjusted 
α=0.012). Ten participants were excluded from the fMRI Data due to elevated movement 
parameters (n=2), technical problems (n=4), response to catch trials (n=2) or unphysiological 
high sAA levels (n=2).  
 
2.2.3. Hormonal determinations of cortisol and alpha-amylase  
 
Saliva samples were collected using Salivetten® (Sarstedt, Nümbrecht, Germany). Subjects 
were instructed to gently chew the swabs in order to stimulate saliva flow. Outside the 
scanner, swabs were directly passed to the subject by the study personnel. During the scanner 
session, subjects lying on the MRI table were put back into home position. Study personnel 
entered the scanner room and collected the sample, avoiding any movements for subjects. All 
saliva samples were stored a −20 °C until being assayed at the end of the study. Concentration 
of sAA was measured by an enzyme kinetic method: saliva was processed on a Genesis 
RSP8/150 liquid handling system (Tecan, Crailsheim, Germany). First, saliva was diluted 
1:625 with double-distilled water by the liquid handling system. Twenty microliters of diluted 
saliva and standard were then transferred into standard transparent 96-well microplates (Roth, 
Karlsruhe, Germany). Standard was prepared from “Calibrator f.a.s.” solution (Roche 
Diagnostics, Mannheim, Germany) with concentrations of 326, 163, 81.5, 40.75, 20.38, 10.19, 
and 5.01 U/ml alpha-amylase, respectively, and bidest water as zero standard. After that, 80 
ml of substrate reagent (a-amylase EPS Sys, Roche Diagnostics, Mannheim, Germany) were 
pipetted into each well using a multichannel pipette. The microplate containing sample and 
substrate was then warmed to 371C by incubation in a waterbath for 90 s. Immediately 
afterwards, a first interference measurement was obtained at a wavelength of 405 nm using a 
standard ELISA reader (Anthos Labtech HT2, Anthos, Krefeld, Germany). The plate was then 
incubated for another 5 min at 371C in the waterbath, before a second measurement at 405 nm 
was taken. Increases in absorbance were calculated for unknowns and standards. Increases of 
absorbance of diluted samples were transformed to alpha-amylase concentrations using a 
linear regression calculated for each microplate (Graphpad Prism 4.0c for MacOSX, 
Graphpad Software, San Diego, CA). Inter- and intra-assay variation was below 10%. 
Analysis of cortisol concentrations was carried out by means of salivary cortisol 
immunoassay with time-resolved fluorescence endpoint detection. All samples were run in 
duplicate in the run on the same kit. Cortisol levels were expressed in nmol/l, internal and 
external controls were included in the assays. The intra- and inter-assay variation coefficients 
ranged between 4.0–6.7% and 7.1– 9.0%, respectively. All analyses were conducted at the 
psychoendocrinological laboratory, Chair of Biopsychology, Technische Universität Dresden.  
 
2.2.4. Data parameterization  
 
In addition to profile plots of state affectivity and hormonal changes from the entire lab visit 
we calculated peak measures for mood dimensions, sAA and cortisol during the scanner 
session (T3–T6). In order to compare high and low hormonal responders regarding trait 
characteristics, baseline to peak values (BL-Peak) were computed. Assuming a certain 
habituation time to the lab environment we employed T2 as baseline value and subtracted it 
from the MRI peak measure. Subjects exceeding cortisol BL-Peak values of 2.5 nmol/l were 
classified as responders (Wust et al., 2000). Since comparable conventions are not available 
for sAA, we used a median split procedure on the BL-Peak value in order to distinguish 
between high and low sAA level groups. SAA samples from T1 to T4 were missing for one 
subject, so that BL-Peak values were calculated for n=38 subjects. In case of single missing 
values (insufficient saliva samples cortisol: n=2; abnormally high sAA: n=3) we used a linear 
interpolation from the pre- and proceeding values to calculate an estimate.  
 
2.2.5. Statistical analysis  
 
Mood and hormonal changes were tested using a one-factorial analysis of variance (ANOVA) 
with repeated measurements on the factor “sampling point” and subsequent pairwise 
comparisons. Greenhouse–Geisser adjustments were applied when appropriate. Partial eta2 
were transformed into Cohen's f2 as effect size measure (0.10=small effects; 0.25=medium 
effects; 0.40=large effects; Cohen, 1983). Associations between state affectivity and 
hormonal measures were calculated using Pearson's correlations that were corrected for 
multiple comparisons (Bonferroni corrections; adjusted α=0.007). Differences between 
cortisol responders vs. non-responders and sAA high vs. low level groups were analyzed 
using a two-factorial ANOVA with repeated measurements on the factor “sampling point” 
and the between-subjects factor “group”. We used this ANOVA approach in order to test for 
systematic differences between subgroups that were not specific for the scanner session (e.g. 
baseline differences or different hormonal levels outside the scanner session time-window). 
Demographic characteristics and state and trait affectivity were tested using chi2, student's t-
tests for independent samples. Non-parametric tests (Mann–Whitney U-test) where used when 
appropriate.  
 
 
3. Results  
 
3.1. Mood dimensions  
 
As displayed in Fig. 2, all three mood dimensions changed significantly during the lab visit 
(valence: F(5, 175)=6.15; p<0.001; f2=0.42; calmness: F(5, 175)=5.31; p<0.001; f2=0.39; 
alertness: F(3, 122)=24.08; p<0.001; f2=0.83). Pairwise comparisons showed that subjects 
reported lower valence ratings after the training session. This level remained unchanged 
during MRI preparation and the first run. After the structural scan, however, valence 
significantly improved, but went down again after the second run (valence: T1>T2, T3, T4 
p<0.050; T5>T2, p<0.010; T5>T3, T4, T6, p<0.001). A similar course was observed for 
calmness ratings with subjects being most nervous immediately before the first run (calmness: 
T1>T3, p<0.050; T5>T2, p<0.050; T5>T3, T4, p<0.001; T6>T3, T4, p<0.010). In contrast, 
alertness ratings exhibited a differential course. Subjects reported feeling more tired after the 
cognitive task (either training session or MRI run; alertness: T1, T3, T5>T2, T4, T6, p<0.001; 
T3>T5, p<0.050).  
 
Peak valence values, but not calmness or alertness were negatively correlated with peak 
cortisol levels during the MRI session (valence/ cortisol: r=−.45, p=0.004; calmness/cortisol: 
r=−0.233, ns; alertness/ cortisol: r=−0.135, ns). Peak sAA levels, on the other hand, were not 
significantly associated with any of the mood dimensions or with cortisol levels 
(valence/sAA: r=0.092, ns; calmness/sAA: r=0.168, ns; alertness/sAA: r=0.174, ns; 
cortisol/sAA: r=0.201, ns).  
 
3.2. Neuroendocrine data  
 
Changes in hormonal levels during the lab visit are displayed in Fig. 3. ANOVA results 
substantiated significant changes of sAA and cortisol values (alpha-amylase: F(3, 124)=5.76; 
p=0.001; f2=0.40; cortisol: F(2, 66)=6.86; p=0.003; f2=0.43). Pairwise comparisons showed 
that sAA peaked directly before the first run after subjects had entered the scanner (T3) and 
then again after the second run (T6; T3>T5, p<0.001; T3>T1, T2, T4, T6, p<0.01; T5bT4, T6, 
p<0.001). Cortisol levels, however, showed no significant MRI related rise, but a general 
falling trend (T1>T3, p<0.001; T1>T2, T5, T6, p<0.01; T1>T4, p<0.050; T2>T3, p<0.001; 
T2>T6, p<0.050; T6bT4, T5, p<0.010).  
 
We furthermore analyzed differences between sAA high vs. low groups. As expected, 
ANOVA results on sAA levels indicated a main effect of sampling point and a main group 
effect (sampling point: F(4, 136)=7.86, p<0.001, f2=0.46; group: F(1, 35)=16.02, p<0.001, 
f2=0.68).While the main effect of group can be explained by the median split procedure, we 
furthermore observed an interaction effect of group and sampling point, indicating different 
sAA levels at the respective time points in each group. This interaction effect showed 
comparable values during baseline at T2, but significantly increased values throughout the 
entire scanning session (group*sampling point: (F4, 136)=9.23; pN0.001; f2=0.51; T3, T4, T5, 
T6: low level group-high level group, p<0.001; T1: low level group < high level group, 
p<0.01). Moreover, within-subject comparisons showed that the low level subjects were 
lacking a scanner-related peak in sAA as evidenced by a general falling trend over time (low 
level group: T1>T5, p<0.05; T2>T4, T6, p<0.05; T2>T5, p<0.01; T3>T6, p<0.05). In 
contrast, only high sAA level subjects showed a pronounced increase in sAA to T3 and again 
to T6 (high level group: T3>T1, T2, T5, pN0.001; T3>T4, T6, p<0.01; T4>T2, p<0.001; 
T4>T5, p<0.01; T4>T1, p<0.05; T5>T2, p<0.05; T6>T2, p<0.001; T6>T5, p<0.05).  
 
Differences between cortisol responders and non-responders yielded similar results. While the 
main effect of group remained insignificant, ANOVA results showed a main effect of 
sampling point and an interaction effect of sampling point * group (group: F(1, 37)= 2.29, 
p=0.138; f2=0.25); sampling point: F(1, 75)=4.64, p=0.12, f2=0.35; sampling point*group: 
F(2, 75)=18.52, p b0.001, f2=0.71). Responders exhibited elevated cortisol levels throughout 
the scanner session (T4, T5, T6: non-responders < responders, p<0.001) but were comparable 
with non-responders for initial and baseline values. Within-subject comparisons affirmed a 
lacking peak in non-responders (T1>T2, p<0.001; T1, T2>T3, T4, T5, T6, p<0.001; T3, 
T4>T5, T6, p<0.01; T5>T6, p<0.01). Contrary, responders exhibited a pronounced peak from 
T4 to T6 compared to pre-scanner values (T1, T2bT4, T5, p<0.01; T1, T2bT6, p<0.05; 
T3>T4, T5, p<0.001; T3>T6, p<0.01). Three out of five cortisol responders were also in the 
SAA high level group. Due to the limited number of cortisol responders (n=5) we also applied 
non-parametric tests for between and within-subject comparisons. These yielded comparable 
results.  
 
3.3. Correlation between hormonal levels and functional brain activation in the thalamus  
 
The ROI analysis of the thalamic region revealed a time sensitive association for the first, but 
not the second half of the first run between sAA and the BOLD signal for the “invalid short 
cue” trials (endogen shifting condition) within the left thalamus (x=−15, y=−18, z=9; Z=6,84; 
81 voxels; see Fig. 4). We found a significant correlation for beta values and sAA during the 
first seven minutes (e.g., 200 scans), that disappeared during the second half of run 1. No 
significant correlation was observed with regard to the entire run (sAA/1st half: r=0.477, 
p=0.009; sAA/2nd half: r=0.021, ns; sAA/entire run: r=0.212, ns). Associations between beta 
values from endogen shifts and cortisol revealed no significant results (cort/1st half: r=0.111, 
ns; cort/2nd half: r=−0.362, ns; cort/entire run: r=−0.183; ns).  
 
3.4. Demographic variables and trait/state affect  
 
In the next step we aimed to test for psychological markers that could differentiate high from 
low hormonal subgroups. As can be seen in Tables 1a and 1b, neither cortisol nor sAA 
subgroups differed from each other in demographic variables or mood during the scanning 
session (indicated by mood dimension peak values). Cortisol responders showed significantly 
lower BDI II scores, although both groups were markedly below clinical cut-offs (e.g. BDI 
IIN18). Comparable data were also obtained for trait anxiety and claustrophobic fear for 
hormonal subgroups.  
 
 
4. Discussion  
 
Present results show that mood changed significantly during the time course of the assessment 
with subjects being most nervous immediately after entering the MRI. While valence and 
calmness ratings showed similar changes, alertness covaried with the amount of cognitive 
demand. Regarding hormonal reactions, the entire group showed a significant rise in sAA in 
response to the scanner. In contrast, cortisol values did not increase in general. However, five 
(12.8%) subjects reacted with a pronounced cortisol response that continued even beyond the 
end of the scanner session. Peak cortisol values were negatively correlated with peak valence 
during the scanner session. We furthermore observed an association between sAA levels and 
functional brain activation being particularly pronounced during the first, but not the second 
half of run 1. Hormonal responders and non-responders were largely comparable in affective 
trait markers.  
 
4.1. Mood and hormonal changes  
 
Regarding mood fluctuations, we observed differential changes in the dimensions studied, 
pointing towards the incremental value of multidimensional mood assessments compared to 
anxiety ratings only. Subjects were most nervous when entering the scanner. This appears to 
reflect the well known impression verbalized by subjects that participate in an MRI 
examination for the first time. Strong variations were also found in the alertness dimension 
with subjects getting fatigued after performing the visual detection task, regardless of being in 
the scanner or not. Alertness thus varied with performing the task and is likely to reflect 
effects of the cognitive load. From all dimensions, only valence correlated with peak cortisol 
levels during the session.  
 
We cannot exclude the possibility that mood fluctuations are nonspecific for the MRI 
situation, but rather occur in experimental sessions per se. Mood changes in the scanner as 
evidenced by present results could nevertheless influence brain functions. Mood induction is a 
frequent technique used in neuroimaging studies to provoke affective responses (Schneider et 
al., 1994). Unintended mood inductions by the scanner setting itself should thus be taken into 
consideration when interpreting functional activation patterns. On the other hand, mood 
appeared to recover during the structural scan. When designing an fMRI experiment, the 
recreational potential of breaks from the cognitive task should be taken into consideration.  
 
Although no stressor task was involved, sAA levels as an indicator of sympathetic activation 
increased in the entire group. SAA levels were highest during the MRI preparation phase. It 
could be argued, however, that increases in sAA have been influenced by movements 
(walking from the assessment to the scanner room), but this assumption is not supported by 
subgroup analyses. Although all subjects had comparable levels of physical activity only 
those in the high median group showed an increase in sAA. Thus, we conclude that rises in 
sAA levels are specific for the anticipation of entering the scanner. The high median group 
furthermore showed a second peak in sAA at T6. Since subjects maintained in the scanner 
from T3 to T6, the second peak is not likely to be influenced by physical activity, but rather 
appears to solely reflect psychological processes. Anticipating the next run, subjects may have 
aroused themselves after the structural scan.  
 
Regarding HPA axis activation, our results do not demonstrate cortisol responses towards the 
scanner per se. Different results reported by other authors may be ascribed to differences in 
sample size (n=6, Tessner et al., 2006) or characteristics (e.g. adolescents, Eatough et al., 
2009), differences in sampling points (e.g. pre–post measures only), duration of the scanner 
session or technical equipment. In this study, goggles were used for visual presentation. This 
may have reduced the claustrophobic properties of the tomograph. The type of stimulation 
system was not reported in previous studies, comparison remains thus limited. However, a 
subset of subjects (12.8%) from the present sample showed pronounced reactions that were 
comparable to social stressors such as the TSST. In contrast to the SNS that is activated by a 
broad range of unspecific stimuli, the HPA axis responds to specific stressors such as social 
evaluation, novelty of the situation and low sense of control (Dickerson and Kemeny, 2004). 
We were not able to find differences in affective trait markers (general anxiety, 
claustrophobic anxiety) between high and low responders. However, the scanner environment 
may have been interpreted in many different ways by the subjects, especially with regard to 
HPA axis relevant features. Due to the passiveness during the scan and high degree of 
technization some, but not all subjects may have experienced a low sense of control in the 
scanner. Future studies should investigate subjective scanner experiences in more detail.  
 
Moreover, present results show that hormonal changes may follow a different time course 
during the scanning session. For example, sAA levels peaked immediately before the first 
functional run, while cortisol levels in responders peaked during the second run. Thus, 
functional activation patterns from the first and second run may have been differently 
influenced by these two hormonal systems. Studies depending on pre–post differences only 
may fail to detect these changes that are related to different response latencies of the 
respective system. Before averaging several runs, the impact of changing hormonal levels 
during the scanner session should be evaluated.  
 
We only observed an incomplete overlap between cortisol and sAA subgroups since two out 
of five cortisol responders were in the low median sAA group. A rise in cortisol may thus not 
necessarily be accompanied by activation of the amylase system. On the other hand, 
interactions of both systems on emotional processing and memory performance were reported 
by Kukolja et al. (2008a) and van Stegeren et al. (2010). However, the limited number of 
cortisol responders does not allow for a comprehensive analysis of covariances between these 
two systems.  
 
4.2. Interaction between stress hormones and functional activation patterns  
 
As already pointed out, several cortical and subcortical structures that are involved in 
cognitive and affective processes, including prefrontal structures, hippocampi and amygdalae, 
exert a high density of GC-binding receptors (Reul and de Kloet, 1986). Importantly, 
behavioral effects may depend on the binding ratio of gluco- (GR) and mineralcorticoid (MR) 
receptors. Basal HPA activity is associated with MR receptor binding, while phasic cortisol 
secretion additionally affects GR receptors (de Kloet et al., 1998). Depending on the amount 
of cortisol reactivity, stress responses related to the MRI setting may in some, but not all, 
subjects modulate neural activity. As a consequence, interindividual variance in imaging data 
due to different hormonal changes should be anticipated. SAA as an indicator of 
noradrenergic and sympathetic activity is also known to affect cognitive processes and neural 
correlates (McGaugh and Roozendaal, 2002; van Stegeren et al., 2005). The potential impact 
of elevated sAA levels during an fMRI experiment has recently been pointed out by van 
Stegeren et al. (2010). They reported a missing effect of enhanced memory after 
administrating the NA agonist yohimbine compared to a placebo condition. Authors discussed 
that elevated sAA levels in response to the scanning procedure within the drug as well as in 
the placebo group could be accountable for the missing effect. We presented preliminary 
fMRI data that further underline this hypothesis. To test for short lasting NA effects, the first 
run was split in two halves. During the first half, sAA was significantly correlated with left 
medial thalamic activity during the invalid trials where the target appeared to an unexpected 
late time point (endogen shifting); the other conditions were not influenced by NA activity. 
This is in line with Coull et al. (2001) where the NA α2 agonist Clonidine impaired only 
endogenous re-orientation, but not exogenous shifts or temporal orienting per se. Associations 
between the left medial thalamic activity and high NA levels were also reported by Bruhl et 
al. (2010). We did however not observe a correlation for the second half of the first run. This 
parallels findings from behavioral and neuroendocrine data where both sAA levels as well as 
subjective experience of stress peaked prior to the start of the session, but were already 
decreased by the end of first run. These results point towards time-sensitive influences of the 
adrenergic system on attentional functions. Present findings did not show any associations 
between thalamic activity and the cortisol system. Several reasons may account for the 
absence of correlations. First, the HPA axis exhibits longer response latencies than the short 
reacting adrenergic system. Indeed, peak values were observed after the first run. It may thus 
be plausible that cortisol values were rising during the first run, while sAA levels already 
peaked in the beginning. Second, pronounced cortisol reactions were observed in a relatively 
small number of subjects only, showing no effects for the entire group. Finally, the temporal 
orienting task was specifically designed to detect effects of the noradrenergic system. Hence, 
the task may have been not sensitive to cortisol effects, since these have been demonstrated 
for working memory and memory functions (Lupien et al., 2007; Kukolja et al., 2008b; 
Weerda et al., 2010). It may be a valuable task for future studies to employ tasks that are more 
sensitive to cortisol effects and to study the association between these hormonal parameters 
and functional activation patterns of interest in more detail.  
 
4.3. A priori identification of hormonal responders  
 
In order to identify hormonal responders from non-responders, we compared affective trait 
markers such as depressive symptoms, anxiety sensitivity or claustrophobic anxiety. Results 
however, were comparable to a large extent in both groups. Cortisol non-responders showed 
higher BDI values. Since scores were markedly below clinical cut-offs, these cannot be 
interpreted in terms of clinically relevant depressive symptoms. Other authors reported a 
predictive value of claustrophobic anxiety for subjective distress during the MRI or a mock 
assessment (McIsaac et al., 1998; McGlynn et al., 2003, 2007). We did not find such an 
association in the present sample. Future studies are needed to evaluate the predictive value of 
affective trait markers for the experience of MRI related distress.  
 
4.4. Limitations  
 
Results, however, have to be interpreted within the methodological limits of the study.  
 
We cannot exclude the possibility that stress reactions are nonspecific for the MRI situation, 
but rather occur in experimental sessions per se. Although no group comparisons employing a 
second control condition (such as a lab session compared to a scanner session) are available, 
indirect inference for the specificity of MRI-related stressor effects can be derived from 
within-subject control conditions. Although all subjects underwent a lab training session prior 
to the scanner session, significant hormonal changes where observed during the scanner 
session only. Future studies are nevertheless needed that directly compare the impact of 
experiments in- and outside the scanner. Regarding the small amount of cortisol responders, a 
larger sample size would have been preferable, especially for closer characterization of this 
subgroup. Although we carefully screened for previous scanner experience, in a post scanning 
interview three subjects reported having been in a scanner before. The small size of scanner-
experienced subgroup does not allow for further statistical analyses on this potential factor of 
influence. Although scanner-naive and -experienced subjects were equally distributed in the 
hormonal subgroups, future studies are clearly needed to investigate the effect of previous 
scanner experience on stress reactions towards the MRI environment. The selection of 
questionnaires used in this study did not contribute to an a priori characterization of hormonal 
responders; future studies should evaluate the potential benefit of additional markers such as 
controllability of the situation. In order to obtain a high level of internal validity, rather strict 
exclusion criteria were employed, including oral contraceptives, body mass index or any 
history of acute or chronic medical disease. As a consequence, our sample predominantly 
consisted of young and healthy male subjects, reflecting the typical study participant of fMRI 
experiments. The small number of cortisol responders may have been due to these sample 
characteristics; present results may be representative for this kind of studies only.  
 
4.5. Conclusion  
 
In conclusion, we were able to show that the MRI setting can act as a stressor. Subjects 
undergoing a cognitive task in the MRI environment showed a rise in sAA-levels directly 
before scanning onset, but no cortisol responses in general. However, these effects may vary 
due to the population studied (e.g. gender, age, familiarity to the scanner or psychiatric 
characteristics). As already stated in the Introduction, investigation of specific patient groups 
may result in more pronounced stress reactions. Clinical studies should therefore take into 
account that comparison of patient and control groups could be confounded by different stress 
levels.  
 
We showed that stress reactions could serve as an additional source of interindividual 
variance in behavioral and neural data. Future studies are needed to evaluate the impact of 
these confounding variables in functional imaging studies in more detail. How can we deal 
with these unintended reactions? We tried to identify vulnerable subjects; however, first 
attempts were not successful yet. Since it may be difficult to exclude stress responders a 
priori, it is recommended to record intra- and interindividual stress levels in order to integrate 
data as covariates in the fMRI design model. An alternative approach might be to implement 
training activities that familiarize subjects with the scanner and thus reduce stress reactivity. 
This may help obtaining more homogenous hormonal levels in fMRI samples.  
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